An AllTrials project

NCT04089891: A trial that was reported late by Masonic Cancer Center, University of Minnesota

This trial was previously reported as an Applicable Clinical Trial, but is no longer.

Full data

Full entry on NCT04089891
Title A Phase I/II Trial in Patients With Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in Which the Gene Encoding CISH Was Inactivated Using the CRISPR/Cas9 System
Results Status no-longer-act
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Oct. 31, 2019
Completion date Oct. 31, 2024
Required reporting date Oct. 31, 2025, midnight
Actual reporting date None
Date last checked at Aug. 3, 2020
Days late None